We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




New Detection Method Spares Unnecessary Prostate Cancer Treatments

By MedImaging International staff writers
Posted on 18 Apr 2016
Print article
Scanning for prostate cancer for 3D modeling (Photo courtesy of St. George\'s University of London).
Scanning for prostate cancer for 3D modeling (Photo courtesy of St. George\'s University of London).
A novel three-dimensional (3D) cell model that mimics the morphogenesis of acini, the glandular units that constitute the prostate, could help study how prostate cancer (PC) progresses.

Developed by researchers at St. George's University of London, the 3D cellular model monitors the morphogenesis of the glandular structures using microscopy and imaging techniques, which can help identify the intraluminal hyperproliferation of the acini. By identifying the factors that alter the epithelial organization of acini that lead to the intraluminal proliferation, the researchers hope to develop a strategy that can help determine the causes of PC progression.

Using the 3D acini model, the researchers are developing methods that will provide objective measures for patient stratification and disease grading, which could thus complement current clinical classification of patients diagnosed with PC. By doing so, they hope to be able to consistently distinguish aggressive PC from indolent disease, a distinction currently difficult to identify, which often leads to inappropriate treatment and high morbidity and mortality.

“Based on these cell culture models, we believe a test could be developed to assess how invasive a prostate cell could become when taken from a patient,” said principal investigator Ferran Valderrama, PhD, of the SGUL PC cell biology laboratory. “We believe that this information would help to determine the appropriate treatment for the patient, reducing the burden derived from unnecessary over treatment, and overall having a positive outcome in patient survival.”

“The currently available prognostic tests for prostate cancer cannot conclusively tell us whether a tumor will rapidly progress and spread to other tissues, or instead will remain confined to the limits of the prostate,” added Dr. Ferran Valderrama. “Improving current procedures for predicting the outcome of a prostate that presents with ‘suspicious’ characteristics of prostate cancer are necessary. If we were able to determine that outcome in a consistent and conclusive manner, it would be easier to define the best approach for treatment for each individual case.”

Related Links:

St George's University of London
New
Mammo 3D Performance Kits
Mammo 3D Performance Kits
New
Ultrasound Table
General 3-Section Top EA Ultrasound Table
40/80-Slice CT System
uCT 528
Silver Member
Radiographic Positioning Equipment
2-Step Multiview Positioning Platform

Print article

Channels

Ultrasound

view channel
Image: The addition of POC ultrasound can enhance first trimester obstetrical care (Photo courtesy of 123RF)

POC Ultrasound Enhances Early Pregnancy Care and Cuts Emergency Visits

A new study has found that implementing point-of-care ultrasounds (POCUS) in clinics to assess the viability and gestational age of pregnancies in the first trimester improved care for pregnant patients... Read more

Nuclear Medicine

view channel
Image: PSMA-PET/CT images of an 85-year-old patient with hormone-sensitive prostate cancer (Photo courtesy of Dr. Adrien Holzgreve)

Advanced Imaging Reveals Hidden Metastases in High-Risk Prostate Cancer Patients

Prostate-specific membrane antigen–portron emission tomography (PSMA-PET) imaging has become an essential tool in transforming the way prostate cancer is staged. Using small amounts of radioactive “tracers,”... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.